Moonjeong Choi
Chinju, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Caveolin-2 controls preadipocyte survival in the mitotic clonal expansion for adipogenesis.
Journal: Biochimica et biophysica acta. Molecular cell research
Published: March 21, 2024
Caveolin-2 palmitoylation turnover facilitates insulin receptor substrate-1-directed lipid metabolism by insulin receptor tyrosine kinase.
Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: October 19, 2023
A Case Presenting with Neuromyelitis Optica Spectrum Disorder and Infectious Polyradiculitis Following BNT162b2 Vaccination and COVID-19.
Journal: Vaccines
Published: June 01, 2022
Epigenetic regulation of Cebpb activation by pY19-Caveolin-2 at the nuclear periphery in association with the nuclear lamina.
Journal: Biochimica et biophysica acta. Molecular cell research
Published: May 03, 2022
Flotillin-1 palmitoylation turnover by APT-1 and ZDHHC-19 promotes cervical cancer progression by suppressing IGF-1 receptor desensitization and proteostasis.
Journal: Cancer gene therapy
Published: March 02, 2022
N-myristoylation regulates insulin-induced phosphorylation and ubiquitination of Caveolin-2 for insulin signaling.
Journal: Biochemical and biophysical research communications
Published: August 17, 2020
Chitosan-based nitric oxide-releasing dressing for anti-biofilm and in vivo healing activities in MRSA biofilm-infected wounds.
Journal: International journal of biological macromolecules
Published: July 08, 2019
Alternative translation initiation of Caveolin-2 desensitizes insulin signaling through dephosphorylation of insulin receptor by PTP1B and causes insulin resistance.
Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: January 04, 2018
A-type lamin-dependent homo-oligomerization for pY19-Caveolin-2 to function as an insulin-response epigenetic regulator.
Journal: Biochimica et biophysica acta
Published: April 12, 2016
Colon-targeted delivery of budesonide using dual pH- and time-dependent polymeric nanoparticles for colitis therapy.
Journal: Drug design, development and therapy
Published: August 01, 2015
Enhanced therapeutic efficacy of budesonide in experimental colitis with enzyme/pH dual-sensitive polymeric nanoparticles.
Journal: International journal of nanomedicine
Published: July 28, 2015
Last Updated: 09/26/2026